Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeEXECUTIVESDr. Catherine Y. Spong New Editor-in-Chief of Contemporary OB/GYN®

Dr. Catherine Y. Spong New Editor-in-Chief of Contemporary OB/GYN®

Contemporary OB/GYN®, a multimedia platform that provides obstetricians and gynecologists with expert advice and critical articles from top-tier physician-authors, announced that Dr. Catherine Y. Spong is their new editor-in-chief.

“Aside from the strong clinical expertise that Spong brings to Contemporary OB/GYN®, her experiences also provide a unique set of perspectives on broad aspects of the OB-GYN practice,” said Mike Hennessy Jr., president, and CEO of MJH Life Sciences, the parent company of Contemporary OB/GYN®. “As we continue to enhance our content portfolio for our readers, we are excited to welcome Spong and carry out her initiative to provide clear, concise, plain-language insight on topics confronted by OB-GYNs in day-to-day practice.”

Spong is a professor and vice-chair in the department of obstetrics and gynecology at The University of Texas Southwestern Medical Center, where she also serves as the chief of the department’s division of maternal-fetal medicine. Spong specializes in prematurity, fetal complications, and improving outcomes in children. Her clinical responsibilities are in the Parkland Health and Hospital System in Dallas. She holds the Gillette professorship of obstetrics and gynecology.

“While Spong’s professional focus lies in the field of obstetrics, her vision for Contemporary OB/GYN® goes well beyond that aspect of female care,” said Aviva Belsky, group publisher of Contemporary OB/GYN®. “In catering our content to the current learners of the specialty, we hope to address the topical issues faced by experts in the field and expand our venues for information dissemination.”

Spong’s all-encompassing research interests include the developing fetus, improving the understanding of stillbirth, fetal surgery for myelomeningocele, Zika in pregnancy and the human placenta. She holds several patents for neuroprotective agents that help prevent fetal injury. Spong is also a passionate advocate for inclusion in research for underrepresented groups.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy